Optimization of the process variables of roller compaction, on the basis of granules characteristics (flow, mechanical strength, and disintegration behavior): an application of SeDeM-ODT expert system

References

• Kachrimanis K, Malamataris S. Compact size and mechanical strength of pharmaceutical diluents. Eur J Pharm Sci. 2005;24:169–177.
   PubMed Web of Science ®Google Scholar
• Tan X, Hu J. Investigation for the quality factors on the tablets containing medicated pellets. Saudi Pharm J. 2016;24:507–514.
   PubMed Web of Science ®Google Scholar
• Mangwandi C, Tao LJ, Albadarin AB, et al. High shear granulation of binary mixtures: effect of powder composition on granule properties. Powder Technol. 2015;270:424–434.
   Web of Science ®Google Scholar
• Gangurde AB, Sav AK, Javeer SD, et al. Modified extrusion-spheronization as a technique of microencapsulation for stabilization of choline bitartrate using hydrogenated soya bean oil. Int J Pharma Investig. 2015;5:275–283.
   PubMed Web of Science ®Google Scholar
• Perez-Gandarillas L, Mazor A, Souriou D, et al. Compaction behaviour of dry granulated binary mixtures. Powder Technol. 2015;285:62–67.
   Web of Science ®Google Scholar
• Yu S, Gururajan B, Reynolds G, et al. A comparative study of roll compaction of free-flowing and cohesive pharmaceutical powders. Int J Pharm. 2012;428:39–47.
   PubMed Web of Science ®Google Scholar
• Haware RV, Tho I, Bauer-Brandl A. Multivariate analysis of relationships between material properties, process parameters and tablet tensile strength for a-lactose monohydrates. Eur J Pharm Biopharm. 2009;73:424–431.
   PubMed Web of Science ®Google Scholar
• Sinka IC, Motazedian F, Cocks ACF, et al. The effect of processing parameters on pharmaceutical tablet properties. Powder Technol. 2009;189:276–284.
   Web of Science ®Google Scholar
• Yu S, Adams M, Gururajan B, et al. The effects of lubrication on roll compaction, ribbon milling and tabletting. Chem Eng Sci. 2013;86:9–18.
   Web of Science ®Google Scholar
• Kleinebudde P. Roll compaction/dry granulation: pharmaceutical applications. Eur J Pharm Biopharm. 2004;58:317–326.
   PubMed Web of Science ®Google Scholar
• Souihi N, Dumarey M, Wikström H, et al. A quality by design approach to investigate the effect of mannitol and dicalcium phosphate qualities on roll compaction. Int J Pharm. 2013;447:47–61.
   PubMed Web of Science ®Google Scholar
• Singh R, Ierapetritou M, Ramachandran R. An engineering study on the enhanced control and operation of continuous manufacturing of pharmaceutical tablets via roller compaction. Int J Pharm. 2012;438:307–326.
   PubMed Web of Science ®Google Scholar
• Dumarey M, Wikström H, Fransson M, et al. Combining experimental design and orthogonal projections to latent structures to study the influence of microcrystalline cellulose properties on roll compaction. Int J Pharm. 2011;416:110–119.
   PubMed Web of Science ®Google Scholar
• Freitag F, Reincke K, Runge J, et al. How do roll compaction/dry granulation affect the tableting behavior of inorganic materials? Microhardness of ribbons and mercury porosimetry measurements of tablets. Eur J Pharm. 2004;22:325–333.
   Google Scholar
• Inghelbrecht S, Remon JP. Roller compaction and tabletting of micro crystalline cellulose drug mixture. Int J Pharm. 1998;161:215–224.
   Web of Science ®Google Scholar
• Fichtner F, Rasmuson A, Alderborn G. Particle size distribution and evolution in tablet structure during and after compaction. Int J Pharm. 2005;292:211–225.
   PubMedGoogle Scholar
• Turkoglu M, Aydin I, Murray M, et al. Modeling of a roller-compaction process using neural networks and genetic algorithms. Eur J Pharm Biopharm. 1999;48:239–245.
   PubMed Web of Science ®Google Scholar
• Bacher C, Olsen PM, Bertelsen P, et al. Compressibility and compactibility of granules produced by wet and dry granulation. Int J Pharm. 2008;358:69–74.
   PubMed Web of Science ®Google Scholar
• Aguilar-Díaz JE, García-Montoya E, Pérez-Lozano P, et al. The use of the SeDeM Diagram expert system to determine the suitability of diluents–disintegrants for direct compression and their use in formulation of ODT. Eur J Pharm Biopharm. 2009;73:414–423.
   PubMed Web of Science ®Google Scholar
• Aguilar-Díaz JE, García-Montoya E, Suñe-Negre JM, et al. Predicting orally disintegrating tablets formulations of ibuprophen tablets: an application of the new SeDeM-ODT expert system. Eur J Pharm Biopharm. 2012;80:638–648.
   PubMed Web of Science ®Google Scholar
• Perez P, Sunenegre J, Minarro M, et al. A new expert systems (SeDeM Diagram) for control batch powder formulation and pre formulation drug products. Eur J Pharm Biopharm. 2006;64:351–359.
   PubMed Web of Science ®Google Scholar
• Suñé-Negre JM, Pérez-Lozano P, Roig M, et al. Optimization of parameters of the SeDeM diagram expert System: Hausner index (IH) and relative humidity (%RH). Eur J Pharm Biopharm. 2011;79:464–472.
   PubMed Web of Science ®Google Scholar
• Khan A, Iqbal Z, Ibrahim M, et al. Prediction of the effect of taste masking on disintegration behavior, mechanical strength and rheological characteristics of highly water soluble drug (itopride HCl); an application of SeDeM-ODT expert system. Powder Technol. 2015;284:411–417.
   Web of Science ®Google Scholar
• Liltorp K, Larsen TG, Willumsen B, et al. Solid state compatibility studies with tablet excipients using non thermal methods. J Pharm Biomed Anal. 2011;55:424–428.
   PubMed Web of Science ®Google Scholar
• The United States Pharmacopeia and National Formulary USP 38–NF 33. Rockville, MD: The United States Pharmacopeial Convention, Inc.; 2012.
   Google Scholar
• European Pharmacopoeia. 6th ed. Strasbourg, France: Council of Europe; 2008.
   Google Scholar
• Kawakami K. Dynamics of ribavirin glass in the sub-Tg temperature region. J Phys Chem B. 2011;115:11375–11381.
   PubMed Web of Science ®Google Scholar
• Poynard T, Marcellin P, Lee SS, et al. Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. Lancet. 2002;352:1426–1432.
   Google Scholar
• Charoo NA, Shamsher AA, Zidan AS, et al. Quality by design approach for formulation development: a case study of dispersible tablets. Int J Pharm. 2012;423:167–178.
   PubMed Web of Science ®Google Scholar